U07.1 U07.1
Conditions
Interventions
Group 1: Phase of acute infection: patients document vital signs and symptoms ??daily using electronic devices and symptom questionnaires for at least 28 days
Group 2: Phase of post-/Long-Covid: patie
Sponsors
Universitätsklinikum Frankfurt, Medizinische Klinik 1
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: positiv PCR Test SARS-CoV-2
Exclusion criteria
Exclusion criteria: No access to a smartphone; pregnancy (only Aachen)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The use of the digital health application improves the treatment management of Covid-19 patients by 1. regularly recording vital signs and symptoms 2. collection of patient reported outcomes 3. exchange of data and information patients and physicians. Assessment via questionnaires on usability / user acceptance (patients and physicians); qualitative interviews on usability / user acceptance (patients and physicians); EQ-5D-3L: Health-related quality of life; Psychological Screening (PHQ-4, PTTS-10); assessment of current symptoms, relevant previous illnesses, medication plan; vital signs (pulse, blood pressure, body temperature, oxygen saturation) in the acute phase; parameters of lung function (FVC, FEV1, peak flow) and activity data (number of steps) in the post-acute / rehabilitation phase | — |
Secondary
| Measure | Time frame |
|---|---|
| The use of the digital health application increases patient sovereignty. The use of the digital health application improves shared decision-making between doctor and patient. The use of the digital health application increases patient safety. The use of the digital health application improves the alignment of treatment with guidelines and recognized standards. Evaluation by the same parameters as the primary endpoint. | — |
Countries
Germany
Contacts
Public ContactBeate S. Müller
Institut für Allgemeinmedizin, Goethe-Universität Frankfurt am Main
Outcome results
None listed